Sue has more than 30 years’ experience as a pharmaceutical, biotechnology and medical technology executive having held senior roles in corporate, medical, commercial and business development at ScheringPlough Corporation (now Merck), Amgen, Bristol-Myers Squibb,  Mesoblast Ltd and MTPConnect. Sue has also served as CEO and a Board member of several ASX, AIM and NASDAQ listed companies in the Healthtech sector Sue is a Non-Executive Director of Planet Innovation Holdings Ltd, Rhythm Biosciences Ltd, ATSE (Academy of Technology and Engineering) and OMICO (Australian Genomic Cancer Medicines Ltd). Sue is also a member of the NSW Govn Innovation and Productivity Council, Fellow of the Australian Academy of Technology and Engineering (ATSE) and Fellow/Graduate of Australian Institute of Company Directors (AICD). Sue is also appointed to several academic and government advisory boards including with Commonwealth Dept of Health, DISR, CSIRO, DMTC (Defence) and Asialink Business. Sue brings a unique set of experiences in technology commercialisation, strategic planning, capital markets and fund raising, M&A and alliance management. Her broad commercial and technical experience is underpinned by a Bachelor of Pharmacy from the University of Queensland, a Master of Laws from Deakin University and a Master of Marketing from Melbourne Business School.